Cell Press Delivers the News Announcing Cell DNA – Daily News Aggregator
CAMBRIDGE, Mass., USA, November 12, 2010 – To enable scientists to easily keep up-to-date with life science focused news and information, Cell Press is delighted to announce the launch of Cell DNA (Daily News Aggregator, accessible online at http://news.cell.com.
Cell DNA is a news aggregator that compiles life sciences-focused news stories from an extensive range sources and delivers them online, and in a daily email digest format, free of charge to subscribers. In addition to receiving daily news digests, readers can comment on, or tweet their favorite news stories, and even submit news for publication.
Readers can subscribe to receive daily news direct to their email in-box on any the following topics: “Cell and Molecular Biology”, “Molecular Medicine”, “Immunology and Microbiology”, “Neuroscience”, “Genetics and Genomics”, “Evolution and Ecology”, “Systems and Computational Biology”, “Biotechnology and Bioengineering”, “Stem Cells”, and “Policy and Society”.
For more information on Cell DNA and to subscribe for alerts, please visit: http://news.cell.com.
# # #
About Cell Press
Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the scientific community it serves. Cell Press primary research journals include the flagship journal Cell, as well as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry & Biology, Cell Metabolism, Cell Host & Microbe, Cell Stem Cell, and, new to Cell Press, Biophysical Journal, and The American Journal of Human Genetics. Cell Press also publishes the Trends family of reviews journals, including Trends in Cell Biology, Trends in Neurosciences, and Trends in Cognitive Sciences. (www.cell.com).
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact
Elisabeth (Lisa) Lyons